Add to Favorites Newsroom RSS Share
New Haven, CT USA

Our News on Newswise


Yale Cancer Center scientists show immunotherapy drug can help patients with metastatic melanoma

When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. Published today in the Journal of Clinical Oncology (JCO), a study by Yale Cancer Center researchers show a checkpoint inhibitor immunotherapy drug has meaningful...
8-Nov-2018 11:05 AM EST Add to Favorites


Yale Cancer Center Finds Patients Choose Cancer Care Based on Hospital Affiliations

Branding matters when it comes to choosing a hospital, according to a new novel study by Yale Cancer Center (YCC) researchers published in the journal Annals of Surgical Oncology.
7-Nov-2018 9:30 AM EST Add to Favorites


Yale Cancer Center investigators show recommended, but underused treatment for rare blood cancer saves lives

U.S. and European guidelines on treating Polycythemia Vera (PV), a potentially deadly blood cancer, call for two treatments for patients with high-risk disease: therapeutic phlebotomy and cytoreductive therapy with a drug called hydroxyurea (HU). HU...
5-Nov-2018 5:05 PM EST Add to Favorites


Antonio Omuro named new Neuro-Oncology Chief at Yale Cancer Center

Antonio Omuro, M.D., has been appointed the new Chief of Neuro-Oncology and a Leader for the Brain Tumor Program at Yale Cancer Center (YCC) and Smilow Cancer Hospital.
5-Nov-2018 10:45 AM EST Add to Favorites


Discovery May Help Provide Clues for Fighting and Treating HPV

Yale Cancer Center (YCC) scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus (HPV) infects cells.
15-Aug-2018 7:05 PM EDT Add to Favorites

Low/No Calorie Soft Drinks Improve Outcomes in Advanced Colon Cancer Patients

Drinking artificially-sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and cancer death, a team of investigators led by a Yale Cancer Center scientist has found. The study was published today in the...
18-Jul-2018 11:05 AM EDT Add to Favorites


Replacing Conventional Cancer Treatment with Complementary Medicine Decreases Patient Survival

People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the...
18-Jul-2018 11:05 AM EDT Add to Favorites


Clinical Trials Take Innovative Approach

Since their arrivals at Yale within the past six years, Patricia LoRusso (right) and Joseph Paul Eder (center)—shown conferring with Clinical Research Coordinator Alexandra Minnella—have overseen a sharp increase in the number of clinical trials...
3-Apr-2018 3:55 PM EDT Add to Favorites

see all news

Our Experts on Newswise


Five Ways to Lower Your Skin Cancer Risk

Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
22-Jun-2018 10:05 AM EDT

Yale Expert Discusses Treatment for Endometrial Cancer

Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
3-Apr-2018 3:55 PM EDT

Expert Speaks on Utilizing Information Technology to Address Oral Chemotherapy Challenges

Utilizing Information Technology to Address Oral Chemotherapy Challenges
26-Mar-2018 2:05 PM EDT


Yale Expert Available to Speak on Medical Marijuana for Children with Cancer

12-Mar-2018 3:05 PM EDT


Overcoming Resistance to Immunotherapy

For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT

Daniel P. Petrylak, MD, on Urothelial Carcinoma: Results of the RANGE Trial

6-Oct-2017 3:05 PM EDT


Yale Expert Wins Prestigious 2017 Warren Alpert Prize

6-Oct-2017 2:05 PM EDT


Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer

22-Sep-2017 4:30 PM EDT

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.


Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 40 years, Yale Cancer Center is one of only 45 Centers in the nation.

Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital at Yale-New Haven. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.


  • Roy Herbst

    Ensign Professor; Professor; Chief

    Lung Cancer, Nsclc, Clinical Trials For Cancer, Yale Cancer Center, Immunotherapy
  • Charles Fuchs

    Professor; Director; Physician-in-Chief

    Colorectal Cancer, Gastrointestinal Cancer, Yale Cancer Center, Cancer epidemiology, Cancer Prevention and Control
  • Anees Chagpar

    Associate Professor; Director, Assistant Director

    Breast Cancer, Yale Cancer Center, breast surgeon, hereditary breast and ovarian cancer syndrome breast cancer, Breast Neoplasms, Global affairs, Healthcare


Anne Doerr
Director of Media Relations


Renee Gaudette
Director of Marketing & Public Affairs


Scott Gettinger
Associate Professor of Medicine

Emily Montemerlo
Marketing Coordinator



Chat now!